ICON plc
The Principal Feasibility Analyst leads feasibility strategy and execution for clinical studies, providing critical support to accelerate patient and site engagement across rare disease programs. This role involves analyzing complex operational and enrollment data to inform study planning, site selection, and enrollment strategies while collaborating with cross-functional teams and senior leadership. The position requires mentoring junior team members and contributing to the continuous improvement of feasibility processes and best practices.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
ICON plc didn’t post a salary, so this is our estimate from similar listings.
3% below the average for this role